Eversana Intouch

OCTOBER 13, 2023

13-16 Payers are taking notice While it is still unclear which SDOH initiatives will flourish, payers are convinced of their potential impact on patient health: in the last year, Aetna, Anthem, CareSource, Humana and Kaiser Permanente have all participated in SDOH programs. August 2015. Accessed July 5, 2023. Health Affairs website.

Pharma 90

Pharma Education Government Pharmaceutical 90

World of DTC Marketing

MAY 4, 2022

A 2015 Commonwealth Fund brie f showed that — before the major provisions of the Affordable Care Act were introduced — the United States had worse outcomes and spent more on health care, primarily because of greater use of medical technology and higher prices, compared to other high-income countries.

Healthcare 210

Healthcare Healthcare Doctors Insurance 210

World of DTC Marketing

OCTOBER 6, 2021

In the first 29 days of the trial, no deaths were reported among the 385 patients who received the drug, while eight of the people who received a placebo died, according to the statement put out by Merck and Ridgeback Biotherapeutics, the two companies that are jointly launching it. Merck charges the U.S.

Food and Drug Administration 198

Food and Drug Administration Government Medicine Food 198

Impetus Digital

MARCH 15, 2024

In fact, for the past five years, the number of treated patients with cancer has seen an average annual increase of 5% globally (1). This competitive intensity tends to focus on smaller patient populations with multiple treatment options (1,2). However, with rapid growth comes growing pains.

Recruitment 78

Recruitment Healthcare Provider Patients Healthcare 78

pharmaphorum

AUGUST 8, 2022

Mark Doyle, co-founder of The Method and creator of the A Life in a Day programme, tells us about the immersive experience he and his team created that allows anyone to live the life of a type 2 diabetes patient for 24 hours. Becoming a diabetes patient. Becoming a diabetes patient.

Patients 52

Patients Healthcare Healthcare Pharma 52

Pharmaceutical Technology

JULY 21, 2022

The pharma industry has deeply rooted environmental, social, and governance (ESG) issues that challenge sustainability. Pharma and medical device companies are implementing AI to transform supply chains and better manage their operations. Staff must be trained on processes and systems and patients made aware of security best practices.

Food and Drug Administration 98

Food and Drug Administration Government Pharma Healthcare 98

European Pharmaceutical Review

JULY 5, 2022

The availability of oral chemotherapy treatments would provide stomach cancer patients with the option of more efficacious drugs with improved tolerability in a more convenient dosage format” The poor clinical outcomes of stomach cancer make it a key target for drug development. New hope for stomach cancer patients.

Patients 80

Patients Food and Drug Administration Side effects Safety 80

pharmaphorum

OCTOBER 6, 2022

Fresh with a new brand identity, the France-headquartered pharma group has pledged to grow its oncology sales from its current objective of €1 billion in 2025 to €3 billion in 2030, continuing a diversification of its business from its traditional focus on cardiovascular diseases. billion and $1.8 billion and $1.8

Sales 83

Sales Pharma Government Medicine 83

Contrarian Sales Techniques

JANUARY 25, 2023

Martin Shkreli, also known as "Pharma Bro," is a former pharmaceutical executive who came to public attention in 2015 when his company, Turing Pharmaceuticals, raised the price of a life-saving drug called Daraprim by more than 5,000%. By doing so, you can make a positive impact on people's lives.

Sales 52

Sales Pharma Distribution Pharmaceutical 52

pharmaphorum

NOVEMBER 25, 2022

The FDA has issued a complete response letter (CRL) to Spectrum Pharma for poziotinib, its pan HER2 inhibitor for a form of lung cancer, according to South Korea’s Hanmi Pharma, which originally developed the drug. Spectrum licensed worldwide rights to poziotinib – excluding Korea and China – from Hanmi in back in 2015.

FDA 94

FDA Side effects Prescription Recruitment 94

pharmaphorum

JANUARY 10, 2023

As two in five pharma leaders say that moving to a consumer-first mindset is a priority for the next two years, digital customer experience agency Graphite Digital is to publish a special edition of its Contradiction Conundrum whitepaper report, released in partnership with Reuters Events Pharma last year.

Pharma 52

Pharma Specialization Sales Biopharma 52

European Pharmaceutical Review

NOVEMBER 22, 2022

a China-based pharma company has announced it has received clearance for its Investigational New Drug (IND) application from the US Food and Drug Administration (FDA) to initiate clinical studies of T21, a 3D-printed medicine that can target specific segments in the colon to more safely deliver oral ulcerative colitis (UC) drugs.

Food and Drug Administration 100

Food and Drug Administration Side effects FDA Medicine 100

European Pharmaceutical Review

OCTOBER 7, 2022

Slow-release formulations were a popular choice for manufacturers, as these varieties reduce the traditional dosage frequency for patients, who only need to take these medications say, once a week. This is especially beneficial as a way of decreasing potential side effects. Leading companies in the oral solid dosage market are Catalent, Inc.,

Manufacturing 79

Manufacturing Marketing Side effects Transportation 79

pharmaphorum

OCTOBER 31, 2022

The small-molecule PIKfyve inhibitor – called VRG50635 – has been administered to the first subject in the phase 1 trial involving healthy volunteers, according to the San Francisco-based biotech, which was founded in 2015 by Alice Zhang and Jason Chen. In preclinical studies VRG50635 has been shown to slow down the degeneration of neurons.

Pharma 125

Pharma Leads Medicine Marketing 125

pharmaphorum

DECEMBER 15, 2022

In recent years, social media has evolved into an essential part of pharma operations, for better or worse. Below, I’m exploring a few ways that pharma teams are using social media and other online collaboration platforms to connect, educate, and influence. Healthcare Provider (HCP) marketing. Connecting peers.

Media 79

Media Healthcare Healthcare Education 79

pharmaphorum

AUGUST 17, 2022

At Sanofi, we are committed to bringing higher quality medicines to patients faster, empowered by our advanced AI drug discovery engine,” Frank Nestle, global head of research and chief scientific officer at Sanofi, said in a statement. In 2019 they struck a major deal with China’s Hansoh pharmaceuticals. “At

Medicine 75

Medicine Pharma Engineering Sales 75

InCrowd

DECEMBER 14, 2022

I’d been in healthcare most of my career but not specifically pharma or market research. I joined in 2015 and have never looked back. I marvel at what our clients do and the hope and relief they provide to patients struggling with difficult—sometimes life threatening—conditions. What is the best part of your job?

Marketing 59

Marketing Pharma Sales Healthcare 59

pharmaphorum

NOVEMBER 6, 2017

The Cancer Vanguard is a bold initiative setup to take leadership in the delivery of the National Cancer Strategy – Achieving World-Class Cancer Outcomes published in 2015 with a key aim of designing and implementing new and increasingly patient centric models of care in Cancer that can benefit and be adopted by the wider national cancer system.

Medicine 52

Medicine Pharma Patients Leads 52

pharmaphorum

OCTOBER 28, 2022

In June, NHSE and NICE published details on the Innovative Medicines Fund, which will help improve patient access to cutting-edge medicines, with a particular focus on rare diseases, and ensure global pharmaceutical and biotech organisations continue to prioritise the UK as a launch destination.

Medicine 107

Medicine Management Marketing Leads 107

European Pharmaceutical Review

JANUARY 24, 2023

This will help to maximise on cross-selling opportunities, providing a seamless and customer-centric experience to Velocity’s pharma and CRO partners. At Parexel, Sandra held roles in Phase I project management and business development, before being promoted to a senior portfolio director in 2015.

Key account management 91

Key account management Physicians Networking Management 91

PM360

JANUARY 25, 2023

Spurred into action by the pandemic, many pharma brands are undertaking or accelerating their digital transformations. As a relative newcomer to pharma (I joined the industry in 2019), several things stand out about the industry’s approach to digital. There are a few key differences in pharma that made this happen.

Media 96

Media Digital Media Marketing Pharma 96

pharmaphorum

JULY 29, 2022

Patients with end-stage renal disease (ESRD) who are on dialysis often need to be treated with anticoagulants to prevent blood clots, but as a result, can experience bleeding side effects. Now, Ionis and Bayer think they have a new drug that could sidestep that risk.

Side effects 70

Side effects FDA Pharma Patients 70

pharmaphorum

DECEMBER 6, 2022

$500 million upfront and a total deal value of up to $5 billion sounds like a deal made by a top-tier pharma company – but in fact it comes from diminutive biotech Summit Therapeutics. The post Little Summit Therapeutics spends big bucks to rebuild pipeline appeared first on.

Patients 52

Patients Pharma Leads Marketing 52

Impetus Digital

JANUARY 3, 2023

A couple of years ago, I first wrote about how social media’s role in the Pharma and healthcare sectors has been growing exponentially. In recent years, social media has evolved into an essential part of Pharma operations, for better or worse. . A version of this article was previously published on PharmaPhorum. Congress Coverage.

Media 52

Media Healthcare Healthcare Recruitment 52

European Pharmaceutical Review

APRIL 27, 2023

The pharma company’s current CEO and Chairman of the Board Dr Giovanni Caforio will retire on November 1 2023. Christopher Boerner’s career trajectory Having worked for BMS since February 2015, Boerner has led the worldwide Commercial and Medical organisations. Dr Caforio will continue as Executive Chairman of the Board.

Medicine 66

Medicine Marketing Government Leads 66

pharmaphorum

DECEMBER 21, 2022

Kite has agreed to acquire all the shares it does not already own in Tmunity – a University of Pennsylvania (PENN) spinout founded in 2015 by CAR-T pioneers Carl June and Bruce Levine – for an undisclosed amount.

Pharma 52

Pharma Manufacturing Engineering Safety 52

PM360

MAY 15, 2023

When a patient meets predetermined triggering criteria, a brand message appears in the EHR. For example, starting in 2015 at Ogilvy, I watched companies that had been using print materials in doctors’ offices begin switching to large electronic tablets in waiting and exams rooms that displayed information for multiple brands.

Marketing 52

Marketing Electronics Doctors Physicians 52

pharmaphorum

OCTOBER 12, 2022

The move ties into an increasing willingness by the pharma industry to use AI to power its drug discovery and development efforts, and to reduce the time and costs involved in getting a new drug to market.

Pharma 62

Pharma Training Networking Leads 62

PM360

AUGUST 9, 2022

According to ZS research, the top pharma companies have more than $230 billion in worldwide revenues at risk from 2022 to 2030 with an estimated 69 blockbusters expected to lose patents during this time. The era of the global pharmaceutical blockbuster is coming to an end. That is why the industry must move into a new era of global marketing.

Specialization 52

Specialization Marketing Pharma Medical 52

pharmaphorum

JULY 27, 2022

“While we have great strengths and enormous potential to grow life sciences in this country, we are falling behind our global competitors when it comes to crucial areas like the use of diagnostics, patient uptake of new medicines, recruitment to clinical trials, and pharmaceutical exports,” he told pharmaphorum. Access to medicines.

Government 89

Government Recruitment Medicine Competition 89

Clarify Health

JULY 13, 2020

The panel included Bhash Parasuraman, PhD, Vice President and BU Lead, Rare Disease Patient & Health Impact, Pfizer , Calum MacRae, MD, PhD, Professor of Medicine at Harvard Medical School , and Surya Singh, MD, President, Singh Healthcare Advisors. million per patient, payers pushed back. It needs to start much earlier.

Pharmaceutical 52

Pharmaceutical Pharma Patients Marketing 52

Evolve Your Success

JUNE 28, 2022

Pharma Sales To Med Device CEO: The Jeff Smith Story Part 2. Despite the very incredible data showing, endoscopic was better for the patient. We wound down Thayer by 2015, but it was at that same moment that a couple of the Providence people and I said, “Why don’t we start an incubator?” — Watch the episode here.

Sales 52

Sales Pharma Medical sales reps Medical sales 52

pharmaphorum

JANUARY 29, 2023

With the population ageing, the need for healthcare is growing fast: between 2015 and 2050, the proportion of the world’s population over 60 years old will nearly double from 12% to 22%, according to the World Health Organization. What do I mean by vital acceleration? But this was just the tip of the iceberg.

Healthcare 86

Healthcare Healthcare Manufacturing Marketing 86

World of DTC Marketing

MAY 26, 2021

Today, Imbruvica is priced at $181,529 per year for a patient taking three pills per day, compared to $99,776 per year at launch. For a patient taking 3 tablets daily, the annual net price of Imbruvica increased from $72,587 in 2013 to $115,533 in 2017 (the last year for which AbbVie provided the Committee data).

Competition 180

Competition Marketing Government Patients 180

pharmaphorum

SEPTEMBER 16, 2022

Citing the transformative therapies available for targets such as tumour necrosis factor (TNF), the pro-inflammatory cytokine interleukin-23 (IL-23), and programmed cell death protein 1 (PD-1) – he explained that “these drugs only achieve the best outcomes in a minority of patients with autoimmunity or cancer”. What, then, is the solution?

Leads 121

Leads Patients Medicine FDA 121

pharmaphorum

OCTOBER 7, 2022

A second, “transitional era” from 2000-2015 was one of older specialty products, including those in multiple sclerosis, early immunological biologics, and oncologics. The launches into these five therapy areas happened from 1988 (the launch of the first statin, Mevacor) onwards.

Competition 71

Competition Marketing Medicine Pharmaceutical 71

Pharmaceutical Technology

MARCH 24, 2023

Until 2010, no regulatory approval pathway for biosimilars existed in the US and the first biosimilar was only approved in the US in 2015. Many pharma companies hold extensive patent protections and have ongoing patent litigation cases. The primary reasons for delayed market entry in the US revolve around patent disputes.

Competition 59

Competition Marketing FDA Physicians 59